Head-to-head · WeighScore
Belle Health vs This Gen Wellness
The verdict
Belle Health takes it — 77/100 to 56.9/100.
Belle Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Belle Health is a national DTC telehealth platform offering compounded semaglutide and tirzepatide with flat-rate pricing — the same monthly cost at every dose, with no escalation surcharge as you titrate up.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Belle Health | This Gen Wellness |
|---|---|---|
| WeighScore | 77/100 | 56.9/100 |
| Grade | C+ | C |
| Scorecard rank | #48 | #405 |
| Semaglutide | $119/mo | Not disclosed |
| Tirzepatide | $199/mo (all doses, 3-month plan, compounded) | Not disclosed |
| Coverage | All 50 states | 1 state |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #48 · C+
Strengths
- Five named compounding pharmacy partners disclosed (Striker, Strive, OptioRx, Enovex, Braun PharmaCare)
- Flat-rate pricing — $119/mo semaglutide, $199/mo tirzepatide — doesn't rise at higher doses
- Free weekly registered-dietitian sessions included
- Operating since 2017
- LegitScript Certified
Where it loses points
- $199 tirzepatide price requires a 3-month bundle commitment
- Compounded medications are not FDA-approved
- Multi-pharmacy model — formulations may differ across orders
- FDA issued this company a warning letter dated 20 February 2026; the letter is public in FDA's warning-letter database
Graded #405 · C
Strengths
- Requires a synchronous live audio-video visit with a New York-licensed clinician — prescriptions are never issued from the intake form alone
- Assessment and clinician review are free; you only pay if treatment is prescribed and you choose to proceed
- Names its legal entity (ThisGen, LLC) and specifies New York governing law in its terms
- No long-term contracts — plans can be paused or stopped
- The same clinician follows your care, with ongoing secure messaging between visits
Where it loses points
- Publishes no prices at all — 'We don't list flat prices on the website'; cost is disclosed only after a clinician reviews your assessment
- Serves New York only — 'we currently operate exclusively for patients located in New York'
- Dispensing pharmacies are not named, only described as 'licensed U.S. pharmacies'
- Does not state whether its semaglutide and tirzepatide are compounded or brand-name
- Does not bill insurance; verifying any reimbursement is the patient's responsibility
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.